Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: May 27, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,063,043

« Back to Dashboard

Which drugs does patent 8,063,043 protect, and when does it expire?

Patent 8,063,043 protects ODOMZO and is included in one NDA.

This patent has forty patent family members in thirty-six countries.

Summary for Patent: 8,063,043

Title:	Salts of N-[6-cis-2,6-dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4'-(t- rifluoromethoxy)[1,1'-biphenyl]-3-carboxamide
Abstract:	Salts of N-[6-(cis-2,6-dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4'-- (trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide are prepared and characterized.
Inventor(s):	Bajwa; Joginder (Elmwood Park, NJ), de la Cruz; Marilyn (Matawan, NJ), Dodd; Stephanie Kay (Ayer, MA), Waykole; Liladhar Murlidhar (Succasunna, NJ), Wu; Raeann (Pine Brook, NJ)
Assignee:	Novartis AG (Basel, CH)
Application Number:	13/061,572
Patent Claim Types: see list of patent claims	Compound; Composition;

Drugs Protected by US Patent 8,063,043

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Sun Pharma Global	ODOMZO	sonidegib phosphate	CAPSULE;ORAL	205266-001	Jul 24, 2015		RX	Yes	Yes	➤ Try a Free Trial	➤ Try a Free Trial	Y	Y			➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted

Foreign Priority and PCT Information for Patent: 8,063,043

PCT Information
PCT Filed	September 15, 2009	PCT Application Number:	PCT/US2009/056918
PCT Publication Date:	March 25, 2010	PCT Publication Number:	WO2010/033481

International Family Members for US Patent 8,063,043

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	073591	➤ Try a Free Trial
Australia	2009293444	➤ Try a Free Trial
Canada	2736751	➤ Try a Free Trial
China	102159570	➤ Try a Free Trial
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo

Accenture

Cerilliant

AstraZeneca

Teva

Healthtrust

Fuji

Covington

Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.